Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 5
2005 7
2006 6
2007 3
2008 3
2009 3
2010 5
2011 6
2012 9
2013 7
2014 6
2015 12
2016 14
2017 9
2018 17
2019 13
2020 20
2021 21
2022 19
2023 21
2024 17
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
Author's Reply.
Walraven J, Jacobs MS, Uyl-de Groot CA. Walraven J, et al. Among authors: uyl de groot ca. Value Health. 2022 Jun;25(6):1058-1059. doi: 10.1016/j.jval.2022.01.018. Epub 2022 Mar 9. Value Health. 2022. PMID: 35279369 Free article. No abstract available.
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.
Chamuleau MED, Stenner F, Chitu DA, Novak U, Minnema MC, Geerts P, Stevens WBC, Zenz T, van Imhoff GW, Wu KL, Demandt AMP, Kersten MJ, Terpstra WE, Tick LW, Deeren D, Van Den Neste E, Gregor M, Veelken H, Böhmer LH, Caspar CB, Mutsaers P, Refos JM, Sewsaran R, Fu L, Seefat RL, Uyl-de Groot CA, Dirnhofer S, Van Den Brand M, de Jong D, Nijland M, Lugtenburg P. Chamuleau MED, et al. Among authors: uyl de groot ca. Lancet Haematol. 2023 Dec;10(12):e966-e975. doi: 10.1016/S2352-3026(23)00279-X. Epub 2023 Oct 31. Lancet Haematol. 2023. PMID: 37922925 Clinical Trial.
Challenges and controversies in resectable non-small cell lung cancer: a clinician's perspective.
Houda I, Dickhoff C, Uyl-de Groot CA, Damhuis RAM, Reguart N, Provencio M, Levy A, Dziadziuszko R, Pompili C, Di Maio M, Thomas M, Brunelli A, Popat S, Senan S, Bahce I. Houda I, et al. Among authors: uyl de groot ca. Lancet Reg Health Eur. 2024 Mar 1;38:100841. doi: 10.1016/j.lanepe.2024.100841. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38476749 Free PMC article. Review.
[Loss is gain? Discarding TNF-α inhibitors].
Versteegh MM, Attema AE, Uyl-de Groot CA. Versteegh MM, et al. Among authors: uyl de groot ca. Ned Tijdschr Geneeskd. 2019 Mar 21;163:D3709. Ned Tijdschr Geneeskd. 2019. PMID: 30945830 Review. Dutch.
New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe.
Houda I, Dickhoff C, Uyl-de Groot CA, Reguart N, Provencio M, Levy A, Dziadziuszko R, Pompili C, Di Maio M, Thomas M, Brunelli A, Popat S, Senan S, Bahce I. Houda I, et al. Among authors: uyl de groot ca. Lancet Reg Health Eur. 2024 Mar 4;38:100840. doi: 10.1016/j.lanepe.2024.100840. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38476748 Free PMC article. Review.
Results from Expanded Access Programs: A Review of Academic Literature.
Polak TB, Cucchi DGJ, Schelhaas J, Ahmed SS, Khoshnaw N, van Rosmalen J, Uyl-de Groot CA. Polak TB, et al. Among authors: uyl de groot ca. Drugs. 2023 Jun;83(9):795-805. doi: 10.1007/s40265-023-01879-4. Epub 2023 May 18. Drugs. 2023. PMID: 37199856 Free PMC article.
Two decades of targeted therapies in acute myeloid leukemia.
Cucchi DGJ, Polak TB, Ossenkoppele GJ, Uyl-De Groot CA, Cloos J, Zweegman S, Janssen JJWM. Cucchi DGJ, et al. Among authors: uyl de groot ca. Leukemia. 2021 Mar;35(3):651-660. doi: 10.1038/s41375-021-01164-x. Epub 2021 Feb 15. Leukemia. 2021. PMID: 33589753 Review.
207 results